Alterations of IMP1 Protein in Esophageal and Gastric Cardia Cancer and Precancerous Lesions
DU Fang,WANG Li-dong,JIAO Xin-ying,SUN Zhe,GAO Shan-shan,FAN Zong-min,HE Xin,GUO Tao,QI Yi-jun,Yu Wei-wei,Wang Zhi-qing,JIANG Ya-nan,CHANG Zhi-wei,LI Ji-lin,CHANG Fu-bao,GUO Hua-qin,YIN Yan-Chun,NIU Mu,LI Jiang-man
DOI: https://doi.org/10.3969/j.issn.1001-7399.2006.04.010
2006-01-01
Abstract:Purpose To evaluate the significance of IMP1 protein expression in esophageal cancer, gastric cardia cancer and precancerous lesions. Methods Immunohistochemical staining (ABC method) was undertaken to determine the expression of IMP1 proteins in 123 cases of esophageal cancer and gastric cardia cancer and precancerous lesion. Results Esophagus: the positive rate of IMP1 protein was the highest in normal esophageal epithelia(NOR, 100%), which positive rate declined in the progress of lesion, and there was significant difference(P0.05) between NOR and based cell hyperplasia (BCH,91.67%), NOR and dysplasia (DYS, 85.71%), NOR and squamous cell carcinoma(SCC, 83.33%), BCH and SCC, respectively. Gastric cardia: IMP1 expressed in all grades of lesions. 83.33% in dysplasia (DYS), 54.55% in chronic atrophy gastritis (CAG), and there was significant difference between DYS and normal epithelia(61.11%)(P0.05), CAG and GCA(61.90%)(P0.01). And there was not significant relationship between the positive rate of IMP1 and differentiation extent of SCC and GCA(P0.05).Conclusions The present results demonstrate that the change of IMP1 protein expression is a frequent molecular event in esophageal and gastric cardia precancerous and cancerous lesions, which indicates that the alterations of IMP1 may play an important role in esophageal and gastric cardia carcinogenesis.